<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03654742</url>
  </required_header>
  <id_info>
    <org_study_id>T211/2018</org_study_id>
    <nct_id>NCT03654742</nct_id>
  </id_info>
  <brief_title>Intracapsular Tonsillectomy in Adults</brief_title>
  <official_title>Intracapsular vs Extracapsular Tonsillectomy. A Comparison of Treatment Methods of Recurrent and Chronic Tonsillitis in Adults: a Prospective Single-blinded Randomised Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing the classical extracapsular tonsillectomy (TE) performed with electrosurgery to&#xD;
      intracapsular approaches (SIPT) by coblation or microdebrider. The patient group is adults&#xD;
      with recurrent or chronic tonsillitis&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Extracapsular tonsillectomy (TE) with monopolar electrosurgery is the most commonly used&#xD;
      approach in adult tonsil surgery in Turku University Central Hospital, Finland.&#xD;
&#xD;
      In our study setting we are comparing intracapsular tonsillectomy&#xD;
      (subtotal/intracapsular/partial tonsillectomy (SIPT) ) as the intervention group with&#xD;
      extracapsular tonsillectomy as the control group.&#xD;
&#xD;
      SIPT is done with either coblation or microdebrider and TE with monopolar electrosurgery.&#xD;
&#xD;
      Indications for surgery are recurrent tonsillitis or chronic tonsillitis. The patient group&#xD;
      is adults (16-65 years)&#xD;
&#xD;
      Safety, efficiency and cost-effectiveness are monitored in a prospective, patient-blinded and&#xD;
      randomised study setting.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 27, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>prospective, single-blinded, randomised, controlled</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Patients are masked with numbers and patient records not shown to the outcomes assessor</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative recovery</measure>
    <time_frame>21 days</time_frame>
    <description>Pain post-operatively after discharge as self-reported pain intensity over the past day. Each day is scored with the modified Brief Pain Inventory and recovery is achieved when pain score reaches preset values. Recovery speed defined as pain VAS-score 3 or less at rest; or pain VAS-score 5 or less without regular analgesics use. Daily questionnaire used: Brief Pain Inventory.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analgesics use</measure>
    <time_frame>21 days</time_frame>
    <description>Need for analgesics postoperatively during 21 days. Measured as number of naprometin tablets/ day and the number of tramadol-paracetamol combination tablets/day.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative bleeding</measure>
    <time_frame>21 days</time_frame>
    <description>Bleeding post-operatively at the ward or at any point during 21 days. Measured as 1-4 (1= bleeding, stopped spontaneously, no contact with staff; 2: Contact with ER, bleeding stopped without intervention; 3: Bleeding, needed intervention (packing, topical adrenalin, electrosurgical hemostasis; 4: Needed OR-time, blood transfusion, ward days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Life Quality</measure>
    <time_frame>6 months</time_frame>
    <description>Quality of life as defined by the questionnaires: Tonsillectomy Outcome Inventory 14 &quot;TOI-14&quot; preoperatively and 6 months after operation;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Residual tonsil tissue</measure>
    <time_frame>6 months</time_frame>
    <description>Residual tonsil measured right after surgery is completed and at 6 months follow-up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Revision surgery</measure>
    <time_frame>5 years</time_frame>
    <description>The need of revision surgery after tonsillectomy, recorded with questionnaire: Nordic Tonsil Surgery Register</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Throat problems</measure>
    <time_frame>5 years</time_frame>
    <description>Throat problems as described by the Nordic Tonsil Surgery Register at different time points postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Life quality</measure>
    <time_frame>6 months</time_frame>
    <description>Quality of life as defined by the questionnaires: Glasgow Benefit Inventory &quot;GBI&quot; at 6 months after operation.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Tonsil Disease</condition>
  <condition>Tonsillitis</condition>
  <condition>Tonsillitis Acute</condition>
  <condition>Tonsillitis Chronic</condition>
  <arm_group>
    <arm_group_label>ECTE/Electrosurgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Extracapsular tonsillectomy (ECTE) with monopolar electrosurgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICTE/Microdebrider</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intracapsular tonsillectomy (ICTE) with microdebrider</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICTE/Coblator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intrapsular tonsillectomy (ICTE) with coblator</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>tonsillectomy</intervention_name>
    <description>removal of tonsil tissue as described in the study arms</description>
    <arm_group_label>ECTE/Electrosurgery</arm_group_label>
    <arm_group_label>ICTE/Coblator</arm_group_label>
    <arm_group_label>ICTE/Microdebrider</arm_group_label>
    <other_name>tonsil removal</other_name>
    <other_name>tonsil surgery</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 16-65 years&#xD;
&#xD;
          -  Planned tonsil surgery with informed consent&#xD;
&#xD;
          -  Recurrent or chronic tonsillitis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Less than 1 month old, drained quinsy&#xD;
&#xD;
          -  Acute &quot;hot phase&quot; tonsillitis&#xD;
&#xD;
          -  Previous palatine tonsil surgery&#xD;
&#xD;
          -  Suspicion or confirmation of malignancy&#xD;
&#xD;
          -  High dose analgesics consumption&#xD;
&#xD;
          -  Current CPAP-device usage for treatment of OSAS&#xD;
&#xD;
          -  Untreated gastro-esophageal reflux disease&#xD;
&#xD;
          -  Anticoagulative medication&#xD;
&#xD;
          -  Any condition of hemophilia&#xD;
&#xD;
          -  Pregnancy, lactation&#xD;
&#xD;
          -  Current or positive history of malignant disease (if still active follow-up)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jussi Jero, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Turku University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tapani J. Uusitalo, M.D.</last_name>
    <phone>0405069070</phone>
    <phone_ext>+358</phone_ext>
    <email>uusitalotapani@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>TYKS Korvaklinikka</name>
      <address>
        <city>Turku</city>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tapani J Uusitalo, MD</last_name>
      <phone>0405069070</phone>
      <phone_ext>+358</phone_ext>
      <email>uusitalotapani@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jaakko Piitulainen, MD PhD</last_name>
      <phone>0408373612</phone>
      <phone_ext>+358</phone_ext>
      <email>jaakko.piitulainen@tyks.fi</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>August 29, 2018</study_first_submitted>
  <study_first_submitted_qc>August 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2018</study_first_posted>
  <last_update_submitted>November 11, 2020</last_update_submitted>
  <last_update_submitted_qc>November 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Turku University Hospital</investigator_affiliation>
    <investigator_full_name>Jaakko Piitulainen</investigator_full_name>
    <investigator_title>Consultant</investigator_title>
  </responsible_party>
  <keyword>tonsil surgery</keyword>
  <keyword>tonsillectomy</keyword>
  <keyword>intracapsular</keyword>
  <keyword>microdebrider</keyword>
  <keyword>coblation</keyword>
  <keyword>extracapsular</keyword>
  <keyword>electrosurgery</keyword>
  <keyword>electrocautery</keyword>
  <keyword>adults</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tonsillitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

